SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-13-000239
Filing Date
2013-12-19
Accepted
2013-12-19 12:48:37
Documents
1
Period of Report
2013-12-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6102
  Complete submission text file 0001192482-13-000239.txt   7463
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Issuer) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O QUAKER BIOVENTURES CIRCA CENTRE, 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address
Gavin Brenda D (Reporting) CIK: 0001488182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36208 | Film No.: 131287719